Pharmacotherapy: Optimal blockade of the renin-angiotensin-aldosterone system
- PMID: 23478259
- DOI: 10.1038/nrcardio.2013.28
Pharmacotherapy: Optimal blockade of the renin-angiotensin-aldosterone system
Abstract
Inhibition of the renin–angiotensin–aldosterone system (RAAS) is a successful therapy for hypertension, heart failure, and renal insufficiency. Overdosing of RAAS inhibitors is occasionally observed when several agents are used together, and can cause adverse events such as hypotension, hyperkalaemia, and renal failure. We advocate optimal, rather than complete, RAAS blockade.
Comment in
-
Reply: Optimal renin-angiotensin-aldosterone system blockade--wish fulfilled.Nat Rev Cardiol. 2013 Aug;10(8):486. doi: 10.1038/nrcardio.2013.28-c2. Epub 2013 Jul 2. Nat Rev Cardiol. 2013. PMID: 23817186 No abstract available.
-
Optimal renin-angiotensin system blockade-wishful thinking?Nat Rev Cardiol. 2013 Aug;10(8):486. doi: 10.1038/nrcardio.2013.28-c1. Epub 2013 Jul 2. Nat Rev Cardiol. 2013. PMID: 23817190 No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical